100+ Free ABOG Maternal-Fetal Medicine Practice Questions
Pass your ABOG Maternal-Fetal Medicine Subspecialty Certifying Examination exam on the first try — instant access, no signup required.
A 32-year-old G2P1 with a history of preeclampsia requiring preterm delivery at 33 weeks presents at 11 weeks for prenatal care. Based on USPSTF and ACOG recommendations, at what gestational age and dose should you start low-dose aspirin for preeclampsia prevention?
Key Facts: ABOG Maternal-Fetal Medicine Exam
200
Multiple-Choice Questions (QE)
ABOG Qualifying Exam at Pearson VUE
~4 hours
QE Computer-Based Duration
Single-best-answer MCQ format
$2,195
2026 QE Application Fee
ABOG Subspecialty Qualifying Exam
36 months
ACGME MFM Fellowship Length
AY2021 ABOG standards (18 months core clinical)
July 20, 2026
QE Exam Date
ABOG 2026 subspecialty schedule
2 steps
Qualifying + Certifying
Written MCQ, then oral exam in Dallas
ABOG MFM is a two-step subspecialty certification: a ~4-hour computer-based Qualifying Exam (single-best-answer MCQs at Pearson VUE on July 20, 2026) followed by an oral Certifying Examination in Dallas. Content is drawn from the MFM Guide to Learning and emphasizes obstetric complications (preterm birth, preeclampsia, diabetes, IUGR, multifetal gestation), fetal medicine (cfDNA/NIPT, anatomy ultrasound, fetal therapy), maternal medical/cardiac/critical care (sepsis, PAS, obstetric hemorrhage), and genetics. 2026 QE fee is $2,195; CE fee is $1,275. Passing is criterion-referenced; historical first-time pass rates run ~80-88%.
Sample ABOG Maternal-Fetal Medicine Practice Questions
Try these sample questions to test your ABOG Maternal-Fetal Medicine exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.
1A 32-year-old G2P1 with a history of preeclampsia requiring preterm delivery at 33 weeks presents at 11 weeks for prenatal care. Based on USPSTF and ACOG recommendations, at what gestational age and dose should you start low-dose aspirin for preeclampsia prevention?
2A 28-year-old G1P0 at 34 weeks presents with BP 165/108, headache, and 3+ proteinuria. She has a seizure in triage. Which regimen is the first-line treatment for seizure prophylaxis and eclampsia treatment?
3A 26-year-old G2P1 at 28 weeks presents with regular contractions and cervical dilation 2 cm. Which antenatal corticosteroid regimen reduces neonatal respiratory distress syndrome?
4A 30-year-old G1P0 with a singleton pregnancy and a short cervix of 18 mm discovered on transvaginal ultrasound at 20 weeks has no history of preterm birth. What is the recommended intervention?
5A 34-year-old G3P2 at 31 weeks presents with contractions every 3-4 minutes. Her cervix is 3 cm dilated. In addition to antenatal corticosteroids, which agent reduces cerebral palsy risk in anticipated preterm delivery <32 weeks?
6A 29-year-old G2P1 is diagnosed with gestational diabetes at 26 weeks after a 1-hour 50-g glucose challenge of 172 mg/dL followed by a 3-hour 100-g GTT with fasting 98, 1-hour 192, 2-hour 165, 3-hour 142 (Carpenter-Coustan). What is the initial management?
7A 36-year-old G4P3 with a history of three prior low-transverse cesarean deliveries undergoes ultrasound at 20 weeks showing an anterior placenta previa with loss of retroplacental clear zone, bridging vessels, and placental lacunae. What is the most likely diagnosis?
8A 27-year-old G1P0 at 39 weeks presents with sudden severe abdominal pain and bright red vaginal bleeding. BP is 90/50, HR 125, fetal heart tracing shows late decelerations. The uterus is rigid and tender. What is the most likely diagnosis?
9A 33-year-old G2P1 with a monochorionic-diamniotic twin pregnancy at 20 weeks has ultrasound showing donor twin with oligohydramnios (MVP <2 cm) 'stuck twin' and recipient with polyhydramnios (MVP >8 cm). Neither twin has absent or reversed end-diastolic flow yet. What is the Quintero stage and recommended treatment?
10A 38-year-old G3P2 at 38 weeks with chronic hypertension presents for induction. Intrapartum she develops BP 172/112 persistently. Which antihypertensive is first-line for acute severe hypertension in pregnancy?
About the ABOG Maternal-Fetal Medicine Exam
The ABOG Maternal-Fetal Medicine (MFM) subspecialty certification is a two-step process administered by the American Board of Obstetrics and Gynecology. Step 1 is the Qualifying Examination — a computer-based multiple-choice written exam at Pearson VUE administered on July 20, 2026. Step 2 is the Certifying Examination — an oral exam in Dallas that includes thesis defense, case-list review, and structured cases. Candidates must have completed an ACGME-accredited MFM fellowship (now 36 months with 18 months core clinical including 2 months ICU, 2 months genetics/genomics, 2 months supervisory L&D), hold active ABOG Specialty certification, and successfully defend a thesis. Content follows the ABOG MFM Blueprint (Guide to Learning) and emphasizes management of complex maternal and fetal conditions.
Questions
200 scored questions
Time Limit
Approximately 4 hours (computer-based Qualifying Exam)
Passing Score
Criterion-referenced scaled passing standard (ABOG MFM Division, modified Angoff)
Exam Fee
$2,195 QE application + $1,275 CE fee (ABOG 2026) (American Board of Obstetrics and Gynecology (ABOG) — Division of Maternal-Fetal Medicine)
ABOG Maternal-Fetal Medicine Exam Content Outline
Obstetric Complications (Antepartum, Intrapartum, Postpartum)
Preterm labor and PPROM (17-OHPC, cervical cerclage, tocolysis, betamethasone 12 mg IM q24h x 2, magnesium neuroprotection for <32 weeks), hypertensive disorders (low-dose aspirin 81 mg starting ≤16 weeks, preeclampsia with severe features, HELLP, MgSO4 4-6 g load then 2 g/hr, eclampsia), diabetes in pregnancy (pregestational vs GDM, IADPSG criteria), IUGR/FGR, oligohydramnios/polyhydramnios, multifetal gestation (monochorionicity, TTTS Quintero staging, TAPS), placenta accreta spectrum, obstetric hemorrhage, post-term.
Fetal Medicine, Imaging, and Therapy
First-trimester screening (NT, PAPP-A, hCG), cfDNA/NIPT (detection rate ≥99% for T21), quad screen, detailed anatomy ultrasound (18-22 weeks), fetal echocardiography, Doppler (MCA PSV for anemia, umbilical artery for FGR, ductus venosus), hydrops fetalis (immune vs non-immune, parvovirus B19), fetal arrhythmias, fetal growth restriction, open and fetoscopic fetal surgery (MMC, TTTS laser, FETO for CDH), invasive diagnosis (CVS 10-13 weeks, amniocentesis ≥15 weeks).
Maternal Medical Conditions
Cardiac disease in pregnancy (mWHO classes, peripartum cardiomyopathy, arrhythmias, pulmonary hypertension), VTE (LMWH, antepartum/postpartum thromboprophylaxis), thyroid disease (subclinical hypothyroid, Graves), renal disease, autoimmune (SLE, APS with LAC/anti-β2GP1/ACA), sickle cell, hepatic disease (ICP with bile acids ≥40, AFLP), neurologic disorders (seizure meds, MS), infectious disease (CMV, toxoplasma, Zika, HIV, syphilis, parvovirus, GBS), obesity, transplant.
Genetics, Genomics, and Prenatal Diagnosis
Inheritance patterns (autosomal dominant/recessive, X-linked, mitochondrial), expanded carrier screening, aneuploidy screening (T21, T18, T13, 45,X, sex-chromosome), microarray vs karyotype, WES, cfDNA limitations (confined placental mosaicism, vanishing twin, BMI), single-gene disorders (sickle cell, CF, Tay-Sachs, fragile X), teratogens (ACEi, warfarin, valproate, isotretinoin, methotrexate, lithium), recurrent pregnancy loss genetics.
Critical Care Obstetrics and Resuscitation
ICU admission criteria, septic shock (qSOFA, Surviving Sepsis bundle, empiric antibiotics, lactate), ARDS management in pregnancy (low tidal volume 6 mL/kg IBW, permissive hypercapnia), maternal cardiac arrest (resuscitative hysterotomy within 4-5 min if >20 weeks and no ROSC), massive transfusion (1:1:1 ratio), amniotic fluid embolism, trauma in pregnancy, venous access/central lines, hemodynamic monitoring, vasopressors (norepinephrine first-line).
Ultrasound and Procedural Skills
First/second/third-trimester ultrasound, transvaginal cervical length (<25 mm at 18-24 weeks), biophysical profile (modified BPP with AFI + NST), AFI vs single deepest pocket, MCA PSV >1.5 MoM for anemia, growth biometry, CVS (10-13 weeks), amniocentesis (≥15 weeks, post-procedure loss ~0.1-0.3%), PUBS/cordocentesis, fetal transfusion, intrauterine shunting, amnioinfusion/amnioreduction.
Research, Statistics, and Thesis
Study design (RCT, cohort, case-control, cross-sectional), sensitivity/specificity, PPV/NPV (prevalence-dependent), relative risk vs odds ratio, NNT, types of bias (selection, information, confounding), systematic review and meta-analysis, STROBE/CONSORT reporting guidelines, ABOG thesis requirements, IRB and ethics, survey methodology (≥50% response for questionnaire-based studies).
How to Pass the ABOG Maternal-Fetal Medicine Exam
What You Need to Know
- Passing score: Criterion-referenced scaled passing standard (ABOG MFM Division, modified Angoff)
- Exam length: 200 questions
- Time limit: Approximately 4 hours (computer-based Qualifying Exam)
- Exam fee: $2,195 QE application + $1,275 CE fee (ABOG 2026)
Keys to Passing
- Complete 500+ practice questions
- Score 80%+ consistently before scheduling
- Focus on highest-weighted sections
- Use our AI tutor for tough concepts
ABOG Maternal-Fetal Medicine Study Tips from Top Performers
Frequently Asked Questions
What is the ABOG Maternal-Fetal Medicine subspecialty exam?
ABOG MFM certification is a two-step voluntary subspecialty credential administered by the American Board of Obstetrics and Gynecology. Step 1 is the Qualifying Examination (QE), a computer-based multiple-choice written exam delivered at Pearson VUE testing centers. Step 2 is the Certifying Examination (CE), an oral exam administered at the ABOG National Center in Dallas that includes thesis defense, case-list review, and structured case discussion. Candidates must hold primary ABOG Specialty (OB-GYN) certification, complete an ACGME-accredited MFM fellowship (36 months total with 18 months core clinical including ICU, genetics, and supervisory L&D experiences), and successfully defend a thesis before sitting for the CE.
How many questions are on the ABOG MFM Qualifying Exam and how long is it?
The MFM Qualifying Exam is a computer-based single-best-answer multiple-choice exam delivered at Pearson VUE over approximately 4 hours. Content is drawn from the ABOG MFM Blueprint (Guide to Learning) and covers obstetric complications, fetal medicine and imaging, maternal medical conditions, genetics and genomics, critical care obstetrics, ultrasound and procedural knowledge, and research methods. The 2026 QE is administered on July 20, 2026.
What is the passing score for the ABOG MFM exam?
Both the Qualifying and Certifying Examinations use criterion-referenced scaled passing standards set by the ABOG MFM Division through a modified Angoff standard-setting process. Scores are not curved against peers — candidates are measured against a content-expert performance standard. Score reports include pass/fail plus diagnostic performance by content domain. Historical first-time MFM QE pass rates run approximately 80-88% per the ABOG public pass-rate tool.
What are the eligibility requirements for ABOG MFM certification?
Candidates must (1) hold active primary ABOG Specialty (OB-GYN) certification; (2) complete an ACGME-accredited Maternal-Fetal Medicine fellowship — under the AY2021 revised standards this is 36 months total with 18 months of MFM core clinical experience (including 2 months of genetics/genomics, 2 months of supervisory L&D, and 1 month of ICU); (3) successfully defend an approved thesis before applying for the CE; (4) submit a compliant case list for the CE; and (5) maintain active, unrestricted medical licensure.
How much does the ABOG MFM exam cost?
For 2026, the Subspecialty Qualifying Examination fee is $2,195 when applied for by February 15, 2026, with a $400 late fee if applied March 15 or earlier (total $2,595). The Certifying Examination fee is $1,275 when submitted July 1-31, 2026, with a $400 late fee for August submissions (total $1,675). These fees are set by ABOG and apply across subspecialties. The CE application fee is additional ($1,125 standard; $1,525 with late fee).
When is the 2026 ABOG MFM exam administered?
The 2026 Subspecialty Qualifying Examination is scheduled for July 20, 2026 at Pearson VUE testing centers. The 2026 Subspecialty Certifying Examination is administered in person at the ABOG National Center for Certification and Continuing Education in Dallas during exam weeks of October 5-8, November 2-5, November 16-19, and December 7-10, 2026. Candidates are assigned to one week after application approval (by June 30, 2026).
What are the highest-yield topics on the ABOG MFM exam?
High-yield topics include preeclampsia prophylaxis with low-dose aspirin 81 mg starting ≤16 weeks for high-risk patients (USPSTF/ACOG), magnesium sulfate for seizure prophylaxis (4-6 g load then 2 g/hr) and neuroprotection (<32 weeks), betamethasone 12 mg IM q24h x 2 for lung maturity, cfDNA/NIPT performance (≥99% T21 detection, limitations from vanishing twin/BMI/CPM), monochorionic twin complications (TTTS Quintero staging, TAPS, sFGR), placenta accreta spectrum diagnosis and delivery planning, obstetric hemorrhage/massive transfusion (1:1:1), maternal cardiac disease (mWHO classification), and perinatal infections (CMV, Zika, GBS, syphilis).
How should I study for the ABOG MFM exam?
Use a structured plan during fellowship with focused review in the final 6-9 months before the QE. Start with the ABOG MFM Guide to Learning to understand expected content. Anchor your review on ACOG Practice Bulletins, SMFM Consult Series, and current ACOG/SMFM committee opinions. Master core protocols: preeclampsia with severe features, PPROM, betamethasone/magnesium dosing, cfDNA interpretation, monochorionic twin surveillance, placenta accreta spectrum delivery planning, and critical care obstetrics (sepsis, ARDS, maternal cardiac arrest with resuscitative hysterotomy). Complete thousands of practice questions across all blueprint domains and review statistics/research methods for both QE and CE thesis defense.